Mipharm Spa
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Italy
- Registered address
- VIA BERNARDO QUARANTA 12, MILANO, 20141, Italy (ITA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002807647 · DUNS 514042399
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-02-29
- VAIDrug Quality Assurance2023-09-22
- VAIDrug Quality Assurance2019-10-17
- VAIDrug Quality Assurance2017-02-03
- VAIDrug Quality Assurance2014-02-14
- VAIDrug Quality Assurance2013-09-27
- NAIDrug Quality Assurance2011-06-10
Drugs this plant is listed as making
6 distinct drugs across 6 products name this site in their FDA label.
- Diclofenac PotassiumLeading Pharma, LLC
- dihydroergotamine mesylateOceanside Pharmaceuticals
- Dihydroergotamine Mesylate NasalCipla USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.